Data from clinical samples under conditions where C5a is expected to be elevated indicate that physiological levels of C5a are in the low nM range (10–30 nM) for a variety of clinical indications including intra-abdominal infections [22], sepsis [23] and COVID-19 infection [1], [24]. The gene discussed is C5; the disease is Sepsis.